2-BUTEN-4-OLIDE (2-B40) INHIBITS TYPE-II COLLAGEN-INDUCED ARTHRITIS IN LEWIS RATS
Citation
Y. Takeoka et al., 2-BUTEN-4-OLIDE (2-B40) INHIBITS TYPE-II COLLAGEN-INDUCED ARTHRITIS IN LEWIS RATS, International journal of immunopharmacology, 15(7), 1993, pp. 803-810
Categorie Soggetti
Immunology,"Pharmacology & Pharmacy
SICI code
0192-0561(1993)15:7<803:2(ITCA>2.0.ZU;2-R
Abstract
2-Buten-4-olide (2-B4O) is an endogenous substance which suppresses ap
petite and/or food intake. We studied its effect on type II collagen-i
nduced arthritis (CIA) in Lewis rats, an animal model for human rheuma
toid arthritis. Bovine type II collagen with incomplete Freund's adjuv
ant was injected intradermally into Lewis rats to induce CIA. 2-B4O (5
0 or 100 mg/kg) significantly inhibited the expression of the clinical
symptoms when administered i.p. daily from day 1 to 21 after immuniza
tion. Furthermore, administration of 2-B4O daily from day 15 to 21 sig
nificantly reduced the severity of symptoms in established CIA. In add
ition, the progression of soft tissue swelling and articular bone eros
ions were suppressed by daily administration of 2-B4O. 2-B4O also sign
ificantly suppressed the delayed-type hypersensitivity (DTH) response
to type II collagen at doses of 50 and 100 mg/kg. Finally 2-B4O signif
icantly inhibited the formation of anti-type II collagen antibody at a
dose of 100 mg/kg, but not at 50 mg/kg. These results suggest that 2-
B4O has the strong inhibitory effects and therapeutic usefulness effec
ts on CIA through the suppression of immune responses to type II colla
gen.